APA (7th ed.) Citation

Ng, K., Jain, P., Heer, G., Redman, V., Chagoury, O., Dowswell, G., . . . Ferro, C. (2014). Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): Study protocol for a randomized controlled pilot trial. BioMed Central.

Chicago Style (17th ed.) Citation

Ng, K., et al. Spironolactone to Prevent Cardiovascular Events in Early-stage Chronic Kidney Disease (STOP-CKD): Study Protocol for a Randomized Controlled Pilot Trial. BioMed Central, 2014.

MLA (9th ed.) Citation

Ng, K., et al. Spironolactone to Prevent Cardiovascular Events in Early-stage Chronic Kidney Disease (STOP-CKD): Study Protocol for a Randomized Controlled Pilot Trial. BioMed Central, 2014.

Warning: These citations may not always be 100% accurate.